Cirrhose kliniske forsøg i New York
6 studier for Cirrhose søger deltagere på steder i New York.
Byer i New York
Officiel studietekst (engelsk)
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn
- Basil Clinical, Laurelton
- Icahn School of Medicine at Mount Sinai, New York
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06632444A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
- Columbia University Medical Center, New York
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 30. sep. 2026 · NCT07325526Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- New York Presbyterian/Weill Cornell, New York
- Columbia University Iriving School of Medicine, New York
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 28. sep. 2026 · NCT05832229National Liver Cancer Screening Trial
- The Feinstein Institutes, Northwell Health, Inc., Manhasset
RekruttererFase 4
Alder 18 til 85 · Alle køn · Opdateret 25. sep. 2026 · NCT06084234A Study of SIPLIZUMAB in AILD and LT Patients
- Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 24. nov. 2025 · NCT06455280Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- Weill Cornell Medicine, New York
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore Medical Center, New York
RekruttererObservationsstudie
Alder 18 til 80 · Alle køn · Opdateret 20. okt. 2025 · NCT04613921Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.